Chronic Myelomonocytic Leukemia (CMML) Recruiting Phase 2 Trials for Tacrolimus (DB00864)

IndicationStatusPhase
DBCOND0037697 (Chronic Myelomonocytic Leukemia (CMML))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02663622A Phase II Trial of CD24Fc for the Prevention of Acute GVHD Following Myeloablative Allogeneic HSCTTreatment